drugset / Trial / NCT03154645

Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy

NCT03154645

Phase 1 Completed 92 enrolled Grant S Lipman
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This double blind randomized trial will compare ibuprofen to acetazolamide for the prevention of acute mountain sickness. These drugs have never been directly compared for efficacy. The study population is hikers who are ascending at their own rate under their own power in a true hiking environment at the White Mountain Research Station, Owen Valley Lab (OVL) and Bancroft Station (BAR), Bancroft Peak, White Mountain, California.

Timeline

Start
2017-08-12
Primary completion
2017-10-01
Completion
2017-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 125 mg
Comparator Ibuprofen Small molecule 600 mg